NTRK1 and breast cancer: The Myc gene is frequently amplified in breast cancer and experimental studies indicate that Myc is a downstream transcriptional effector of ErbB2 receptor tyrosine kinase activation, a signaling pathway that is commonly dysregulated and constitutively active in breast cancer [26,27].